छोड़कर सामग्री पर जाएँ

Zydus Life shares rise as US arm gains rights for rare paediatric disease drug

  • द्वारा
  • Latest News

Zydus Lifesciences#39; arm has taken over the development and commercialization of CUTX-101, a product for treating Menkes disease

Read More

​ Zydus Lifesciences#39; arm has taken over the development and commercialization of CUTX-101, a product for treating Menkes disease Zydus Lifesciences#39; arm has taken over the development and commercialization of CUTX-101, a product for treating Menkes disease  Moneycontrol Latest News Read More  

प्रातिक्रिया दे

आपका ईमेल पता प्रकाशित नहीं किया जाएगा. आवश्यक फ़ील्ड चिह्नित हैं *

hi_INहिन्दी